CompletedPHASE3INTERVENTIONAL
Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis
- Sponsor:
- Amgen
- Conditions:
- Osteopenia, Osteoporosis
- Enrollment:
- 4,550
- Started:
- Aug 2007
NCT00523341
Human trials
Where longevity science meets human data: registered trials of aging interventions, pulled daily from ClinicalTrials.gov. Status, phase, sponsor, and enrollment for each.
NCT00523341
NCT04652921
NCT01375959
NCT05571891
NCT03538574
NCT05420142
NCT04623242
NCT04185623
NCT01311115
NCT03964974
NCT02598258
NCT03283462
NCT05497648
NCT04705571
NCT05309161
NCT03467152
NCT03652220
NCT03116399
NCT04053504
NCT04949607
NCT05452395
NCT04739384
NCT05156918
NCT02088190
Literature and preprints via Europe PMC. Trial data from ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine. We store metadata and abstracts and link to every source record. This is educational information, not medical advice.